Machina Capital S.A.S. bought a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 722 shares of the biopharmaceutical company’s stock, valued at approximately $594,000. Other hedge funds and other institutional investors […]